SALVARANI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 80.566
AS - Asia 37.976
EU - Europa 35.138
SA - Sud America 5.893
AF - Africa 816
OC - Oceania 213
Continente sconosciuto - Info sul continente non disponibili 57
Totale 160.659
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 78.873
SG - Singapore 11.555
GB - Regno Unito 10.307
CN - Cina 9.048
IT - Italia 7.300
HK - Hong Kong 5.207
BR - Brasile 4.572
SE - Svezia 4.302
VN - Vietnam 4.187
FI - Finlandia 3.162
DE - Germania 2.481
BD - Bangladesh 2.090
UA - Ucraina 1.598
FR - Francia 1.443
RU - Federazione Russa 1.410
TR - Turchia 1.293
KR - Corea 982
BG - Bulgaria 787
CA - Canada 787
IN - India 687
ID - Indonesia 620
JP - Giappone 562
NL - Olanda 502
AR - Argentina 451
MX - Messico 401
IE - Irlanda 330
IQ - Iraq 327
ES - Italia 238
PK - Pakistan 231
BZ - Belize 227
ZA - Sudafrica 203
EC - Ecuador 198
PL - Polonia 198
AT - Austria 195
AU - Australia 180
AE - Emirati Arabi Uniti 171
CO - Colombia 155
CL - Cile 142
EG - Egitto 121
MA - Marocco 119
VE - Venezuela 115
CH - Svizzera 112
LT - Lituania 110
TN - Tunisia 107
PH - Filippine 106
MY - Malesia 105
BE - Belgio 90
SA - Arabia Saudita 90
PE - Perù 88
CZ - Repubblica Ceca 84
UZ - Uzbekistan 79
HU - Ungheria 78
PY - Paraguay 73
KE - Kenya 70
TH - Thailandia 69
DZ - Algeria 66
JO - Giordania 66
TW - Taiwan 60
NP - Nepal 56
PT - Portogallo 55
IR - Iran 53
DK - Danimarca 51
AZ - Azerbaigian 47
UY - Uruguay 47
BO - Bolivia 42
DO - Repubblica Dominicana 42
RO - Romania 42
CR - Costa Rica 41
GR - Grecia 40
EU - Europa 38
IL - Israele 38
AL - Albania 37
JM - Giamaica 34
RS - Serbia 33
HN - Honduras 31
NZ - Nuova Zelanda 28
GT - Guatemala 27
OM - Oman 26
SN - Senegal 25
BY - Bielorussia 24
KZ - Kazakistan 23
BH - Bahrain 22
EE - Estonia 21
ET - Etiopia 21
LB - Libano 21
KG - Kirghizistan 20
KW - Kuwait 19
PA - Panama 18
LV - Lettonia 17
NI - Nicaragua 17
SY - Repubblica araba siriana 17
NO - Norvegia 16
PS - Palestinian Territory 16
HR - Croazia 14
SK - Slovacchia (Repubblica Slovacca) 14
SV - El Salvador 14
TT - Trinidad e Tobago 14
KH - Cambogia 13
MD - Moldavia 12
NG - Nigeria 12
Totale 160.408
Salva come PNG Salva come JPEG
Città #
Fairfield 8.613
Ashburn 7.174
Singapore 7.170
Santa Clara 6.914
Southend 6.696
Woodbridge 5.937
Hong Kong 5.131
Houston 4.099
Chandler 3.411
Seattle 3.191
Wilmington 2.845
Jacksonville 2.774
San Jose 2.752
Cambridge 2.634
Hefei 2.579
Helsinki 2.558
Ann Arbor 2.339
London 2.235
Dearborn 1.912
Stockholm 1.818
Beijing 1.814
Council Bluffs 1.546
The Dalles 1.401
Modena 1.397
Ho Chi Minh City 1.335
Nyköping 1.168
Los Angeles 1.074
New York 1.046
San Diego 1.002
Hanoi 974
Seoul 904
Milan 802
Chicago 794
Princeton 778
Sofia 751
Dallas 715
Lauterbourg 709
Buffalo 684
Eugene 561
Moscow 549
Jakarta 449
Izmir 427
Munich 390
São Paulo 386
Shanghai 357
Rome 305
Dublin 292
Bologna 277
Tokyo 275
Salt Lake City 270
Frankfurt am Main 242
Toronto 228
Belize City 227
Columbus 225
Boardman 219
Orem 204
Redwood City 199
Atlanta 191
Da Nang 191
Las Vegas 190
Haiphong 167
Rio de Janeiro 160
Nuremberg 148
Phoenix 147
Redondo Beach 138
Mexico City 128
Kent 124
Brooklyn 117
Montreal 117
Miano 116
Guangzhou 115
Warsaw 113
Baghdad 112
Amsterdam 109
Porto Alegre 109
Naples 108
Norwalk 108
Parma 106
Falls Church 105
Elk Grove Village 104
Reggio Emilia 102
San Francisco 102
Tampa 100
Brasília 97
Bremen 97
Johannesburg 97
Boston 96
Florence 96
Nanjing 96
Saint Louis 96
Belo Horizonte 92
Denver 92
Falkenstein 86
Lappeenranta 86
Mumbai 84
Biên Hòa 83
Chennai 83
Ankara 80
Kilburn 80
Reggio Nell'emilia 79
Totale 112.605
Salva come PNG Salva come JPEG
Nome #
64 Cu and fluorescein labeled anti-miRNA peptide nucleic acids for the detection of miRNA expression in living cells 2.009
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.362
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 516
Anti-TNF-α drugs differently affect the TNFa-sTNFR system and monocyte subsets in patients with psoriasis 492
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 456
Prevalence of SARS-CoV-2 (Covid-19) in Italians and in immigrants in an area of Northern Italy (Reggio Emilia) 445
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 405
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria 399
Validation of the classification criteria for cryoglobulinaemic vasculitis 394
Adult Primary Central Nervous System Vasculitis 370
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 360
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 359
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 348
Visual loss and other cranial ischaemic complications in giant cell arteritis 347
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 341
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy 339
Rituximab therapy for Takayasu arteritis: A seven patients experience and a review of the literature 334
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 333
Clinical features of polymyalgia rheumatica and giant cell arteritis 330
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 329
Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Institution 25-Year Experience 326
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 323
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease 322
2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative 320
Acute exacerbation of interstitial lung disease associated with rheumatic disease 320
Retroperitoneal fibrosis 319
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine 318
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 315
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 315
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility 310
Ultrasound Examination of Common Carotid Adventitial Thickness Can Differentiate Takayasu Arteritis and Large Vessel Giant Cell Arteritis 309
Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? 309
Epidemiology of psoriatic arthritis 309
2018 Update of the EULAR recommendations for the management of large vessel vasculitis 309
Comment on: Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis: Reply 309
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 307
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 304
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 303
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 302
Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study 301
Role of PD-L1 in licensing immunoregulatory function of dental pulp mesenchymal stem cells 301
A comprehensive review on the role of mesenchymal stromal/stem cells in the management of rheumatoid arthritis 296
Polymyalgia rheumatica 296
Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations 295
(18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis 294
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome 294
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 293
Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients 289
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 289
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 289
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 288
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 287
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease 287
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice 286
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 285
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 284
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 283
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 283
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 281
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 280
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 280
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 279
Polymyalgia rheumatica 277
Polymyalgia rheumatica and giant-cell arteritis 277
Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica 277
Biotherapies in large vessel vasculitis 276
Imaging of vasculitis: State of the art 276
Anti-drug antibody detection with label-free electrolyte-gated organic field-effect transistors 276
Comment on: Rituximab therapy for takayasu arteritis: A seven patients experience and a review of the literature: Reply 275
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 274
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 274
Unmet Needs in the Pathogenesis and Treatment of Vasculitides 273
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature 271
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 271
Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients 269
Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy 269
EULAR guidelines on ANCA-associated vasculitis in the real life 269
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 268
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 268
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 267
Recent advances in the diagnosis and treatment of polymyalgia rheumatica 267
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 265
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 265
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 265
Giant cell arteritis: Involvement of intracranial arteries 264
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 264
Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study 264
Management of primary and secondary central nervous system vasculitis 263
Psoriatic disease: concepts and implications 262
Biologics in vasculitides: Where do we stand, where do we go from now? 261
The role of infectious agents in the pathogenesis of vasculitis 261
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial 261
2018 update of the EULAR recommendations for the management of Behçet's syndrome 260
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 260
Takayasu's arteritis: A study of 104 Italian patients 259
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease 259
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 258
Contrast-enhanced ultrasound of the carotid artery in patients with large vessel vasculitis: Correlation with positron emission tomography findings 258
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 258
Polymyalgia rheumatica and giant-cell arteritis 257
Totale 32.995
Salva come PNG Salva come JPEG
Categoria #
all - tutte 666.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 666.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021999 0 0 0 0 0 0 0 0 0 0 0 999
2021/202213.164 620 1.475 1.334 950 369 965 861 631 1.513 943 2.021 1.482
2022/202310.863 1.386 756 738 798 1.307 1.559 243 1.046 1.697 225 597 511
2023/20248.281 335 532 425 849 1.815 486 515 1.469 246 216 374 1.019
2024/202527.276 1.171 353 397 2.002 4.675 4.217 1.649 1.345 3.407 2.338 2.530 3.192
2025/202653.569 3.012 2.051 4.890 5.205 4.598 4.220 6.890 3.199 6.756 4.087 4.632 4.029
Totale 162.611